By Industry News
Jacksonville, FL – Oct. 27, 2021 – Next Science Limited, a medical technology company, announced that it will exhibit at the Symposium on Advanced Wound Care Fall meeting (SAWC Fall) from Oct. 29-31. Next Science, whose mission is to heal patients and save lives by addressing the impact of biofilms on human health, will exhibit at Booth No. 718.
Next Science will showcase BLASTX®, an antimicrobial wound gel that is suitable for diabetic wounds, leg ulcers and other pressure wounds. Powered by patented, non-toxic, biofilm-disruption technology, BLASTX deconstructs the bacterial biofilm EPS matrix, destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment. BLASTX is compatible with a broad range of advanced healing modalities, setting the stage for ongoing care.
In a clinical assessment, the Mayo Clinic found that over 12 weeks, patients using BLASTX saw the size of their wounds reduce three times more than study participants who used a standard wound-care product (P < 0.01).1 There were no adverse events related to the biofilm-disrupting BLASTX product while two adverse reactions occurred with the antibiotic control group.
Offering sustained broad-spectrum efficacy for up to five days, BLASTX has been adopted across the United States by hospitals and health care networks, including Kaiser, Scripps, and Steward. Next Science has also partnered with diabetic non-profit organizations, which recognize the lifechanging potential of BLASTX to help reduce the need for lower-limb amputations.
To learn more about BLASTX, and Next Science’s range of other innovative medical products, stop by Booth No. 718 or email at email@example.com.
About Next Science
Next Science develops innovative technologies that apply materials science principles to address, and ultimately resolve, one of the leading causes of antimicrobial resistance: bacterial biofilms.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.